AERI Historical PE Ratio image   This AERI PE ratio history page last updated 11/7/2022
AERI PE History Chart
PeriodPriceAdj. EPSTTMPE
Q3 2022
11/3/2022
15.23-0.27-0.16NA
Q2 2022
8/4/2022
7.37-0.32-0.61NA
Q1 2022
5/5/2022
7.72-0.66-0.96NA
Q4 2021
2/24/2022
5.901.09-1.02NA
Q3 2021
11/4/2021
12.01-0.72-2.90NA
Q2 2021
8/4/2021
15.00-0.67-3.04NA
Q1 2021
5/5/2021
16.84-0.72-3.42NA
Q4 2020
2/25/2021
15.81-0.79-3.54NA
Q3 2020
11/5/2020
10.73-0.86-3.71NA
Q2 2020
8/6/2020
12.10-1.05-3.94NA
Q1 2020
5/6/2020
15.67-0.84-3.69NA
Q4 2019
2/20/2020
19.89-0.96-3.63NA
Q3 2019
11/6/2019
23.82-1.09-3.59NA
Q2 2019
8/7/2019
21.49-0.80-4.23NA
Q1 2019
5/7/2019
38.25-0.78-4.83NA
Q4 2018
2/25/2019
40.18-0.92-4.88NA
Q3 2018
11/6/2018
54.55-1.73-5.34NA
Q2 2018
8/8/2018
64.75-1.40-4.32NA
Q1 2018
5/8/2018
49.95-0.83-3.55NA
Q4 2017
2/28/2018
51.15-1.38-3.34NA
Q3 2017
11/8/2017
63.83-0.71-2.68NA
Q2 2017
8/1/2017
52.95-0.63-2.64NA
Q1 2017
5/2/2017
42.10-0.62-2.73NA
Q4 2016
3/7/2017
49.95-0.72-2.83NA
Q3 2016
11/2/2016
33.60-0.67-2.75NA
Q2 2016
8/3/2016
18.03-0.72-2.64NA
Q1 2016
5/2/2016
16.33-0.72-2.65NA
Q4 2015
3/1/2016
16.76-0.64-2.52NA
Q3 2015
11/3/2015
23.55-0.56-2.46NA
Q2 2015
8/5/2015
17.60-0.73-2.34NA
Q1 2015
5/7/2015
10.44-0.59-2.10NA
Q4 2014
3/2/2015
28.93-0.58-1.79NA
Q3 2014
11/11/2014
24.83-0.44-1.83NA
Q2 2014
8/6/2014
17.18-0.49-12.20NA
Q1 2014
5/12/2014
15.32-0.28NANA
Q4 2013
3/18/2014
21.89-0.62NANA
Q3 2013
12/4/2013
13.60-10.81NANA
AERI Historical PE Ratio Chart
PeriodPriceAdj. EPSAnnualizedPE
Q3 2022
11/3/2022
15.23-0.27-1.08NA
Q2 2022
8/4/2022
7.37-0.32-1.28NA
Q1 2022
5/5/2022
7.72-0.66-2.64NA
Q4 2021
2/24/2022
5.901.094.361.4
Q3 2021
11/4/2021
12.01-0.72-2.88NA
Q2 2021
8/4/2021
15.00-0.67-2.68NA
Q1 2021
5/5/2021
16.84-0.72-2.88NA
Q4 2020
2/25/2021
15.81-0.79-3.16NA
Q3 2020
11/5/2020
10.73-0.86-3.44NA
Q2 2020
8/6/2020
12.10-1.05-4.20NA
Q1 2020
5/6/2020
15.67-0.84-3.36NA
Q4 2019
2/20/2020
19.89-0.96-3.84NA
Q3 2019
11/6/2019
23.82-1.09-4.36NA
Q2 2019
8/7/2019
21.49-0.80-3.20NA
Q1 2019
5/7/2019
38.25-0.78-3.12NA
Q4 2018
2/25/2019
40.18-0.92-3.68NA
Q3 2018
11/6/2018
54.55-1.73-6.92NA
Q2 2018
8/8/2018
64.75-1.40-5.60NA
Q1 2018
5/8/2018
49.95-0.83-3.32NA
Q4 2017
2/28/2018
51.15-1.38-5.52NA
Q3 2017
11/8/2017
63.83-0.71-2.84NA
Q2 2017
8/1/2017
52.95-0.63-2.52NA
Q1 2017
5/2/2017
42.10-0.62-2.48NA
Q4 2016
3/7/2017
49.95-0.72-2.88NA
Q3 2016
11/2/2016
33.60-0.67-2.68NA
Q2 2016
8/3/2016
18.03-0.72-2.88NA
Q1 2016
5/2/2016
16.33-0.72-2.88NA
Q4 2015
3/1/2016
16.76-0.64-2.56NA
Q3 2015
11/3/2015
23.55-0.56-2.24NA
Q2 2015
8/5/2015
17.60-0.73-2.92NA
Q1 2015
5/7/2015
10.44-0.59-2.36NA
Q4 2014
3/2/2015
28.93-0.58-2.32NA
Q3 2014
11/11/2014
24.83-0.44-1.76NA
Q2 2014
8/6/2014
17.18-0.49-1.96NA
Q1 2014
5/12/2014
15.32-0.28-1.12NA
Q4 2013
3/18/2014
21.89-0.62-2.48NA
Q3 2013
12/4/2013
13.60-10.81-43.24NA
Quotes delayed 20 minutes

Email EnvelopeFree AERI Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Aerie Pharmaceuticals (AERI) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

AFIB PE Ratio History
AGEN PE Ratio History
AGIO PE Ratio History
AGL PE Ratio History
AGLE PE Ratio History
AGRX PE Ratio History
AGTC PE Ratio History
AGTI PE Ratio History
AHCO PE Ratio History
AHPI PE Ratio History
On this page we presented the AERI PE Ratio History information for Aerie Pharmaceuticals' stock. The average AERI PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 1.4. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average AERI PE ratio history based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this AERI PE ratio history result, against the recent PE: when this page was posted on 11/4/2022, the most recent closing price for AERI had been 15.22, and the most recent quarterly earnings result, annualized, was 4.36. Meanwhile, the most recent TTM earnings summed to NA. From these numbers, we calculate the recent AERI PE on 11/4/2022 based on annualized quarterly EPS was 3.5. Based on AERI's history, that recent PE is elevated relative to the historical average, with the recent PE 150.0% higher than the historical average PE across our data set for Aerie Pharmaceuticals.

For self directed investors doing their due diligence on AERI or any other given stock, valuation analysis for AERI can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios justify the current stock market value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Aerie Pharmaceuticals PE ratio history — or the PE history for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for next earnings dates and also historical earnings surprises history for AERI. Thanks for visiting, and the next time you need to research AERI PE Ratio History or the PE ratio history for another stock, we hope our site will come to mind as your go-to PE ratio history research resource of choice.

Recommended: Top Ten Hedge Funds Holding SCHP, ST Price Target, FLOW Insider Buying.

 

AERI PE Ratio History | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.